Completed PHASE1 INTERVENTIONAL 2-arm
NCT05634460
Comparison of 5% Potassium Hydroxide With 10% Potassium Hydroxide Solution in Treatment of Molluscum Contagiosum
Sponsor: Combined Military Hospital Abbottabad
Conditions
Molluscum Contagiosum
Interventions
potassium hydroxide
Updated 3 times since 2023 Last updated: Nov 22, 2022 Started: Mar 1, 2022 Primary completion: Aug 31, 2022 Completion: Aug 31, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE1 clinical study on Molluscum Contagiosum, this trial is completed. The trial is conducted by Combined Military Hospital Abbottabad and has accumulated 3 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE1
First recorded
Mar 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Combined Military Hospital Abbottabad
Data source: Combined Military Hospital Abbottabad
For direct contact, visit the study record on ClinicalTrials.gov .